Genetic targeting of adenoviral vectors

被引:116
作者
Krasnykh, VN
Douglas, JT
van Beusechem, VW
机构
[1] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA
[4] Univ Alabama, Div Human Gene Therapy, Birmingham, AL 35294 USA
[5] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
[6] Vrije Univ Amsterdam, Univ Hosp, Dept Med Oncol, Div Gene Therapy, Amsterdam, Netherlands
关键词
D O I
10.1006/mthe.2000.0062
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:391 / 405
页数:15
相关论文
共 185 条
  • [1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
    Arap, W
    Pasqualini, R
    Ruoslahti, E
    [J]. SCIENCE, 1998, 279 (5349) : 377 - 380
  • [2] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [3] Adenovirus type 37 uses sialic acid as a cellular receptor
    Arnberg, N
    Edlund, K
    Kidd, AH
    Wadell, G
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (01) : 42 - 48
  • [4] THE REFINED CRYSTAL-STRUCTURE OF HEXON, THE MAJOR COAT PROTEIN OF ADENOVIRUS TYPE-2, AT 2-CENTER-DOT-9 ANGSTROM RESOLUTION
    ATHAPPILLY, FK
    MURALI, R
    RUX, JJ
    CAI, ZP
    BURNETT, RM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 242 (04) : 430 - 455
  • [5] VITRONECTIN RECEPTOR ANTIBODIES INHIBIT INFECTION OF HELA AND A549 CELLS BY ADENOVIRUS-TYPE-12 BUT NOT BY ADENOVIRUS TYPE-2
    BAI, M
    CAMPISI, L
    FREIMUTH, P
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 5925 - 5932
  • [6] Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries
    Barry, MA
    Dower, WJ
    Johnston, SA
    [J]. NATURE MEDICINE, 1996, 2 (03) : 299 - 305
  • [7] Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial
    Bellon, G
    MichelCalemard, L
    Thouvenot, D
    Jagneaux, V
    Poitevin, F
    Malcus, C
    Accart, N
    Layani, MP
    Aymard, M
    Bernon, H
    Bienvenu, J
    Courtney, M
    Doring, G
    Gilly, B
    Gilly, R
    Lamy, D
    Levrey, H
    Morel, Y
    Paulin, C
    Perraud, F
    Rodillon, L
    Sene, C
    So, S
    TouraineMoulin, F
    Schatz, C
    Pavirani, A
    [J]. HUMAN GENE THERAPY, 1997, 8 (01) : 15 - 25
  • [8] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323
  • [9] Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR
    Bewley, MC
    Springer, K
    Zhang, YB
    Freimuth, P
    Flanagan, JM
    [J]. SCIENCE, 1999, 286 (5444) : 1579 - 1583
  • [10] Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma
    Blackwell, JL
    Miller, CR
    Douglas, JT
    Li, H
    Reynolds, PN
    Carroll, WR
    Peters, GE
    Strong, TV
    Curiel, DT
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (08) : 856 - 863